Rice Technologies for Cervical Cancer Screening and Diagnosis
NCT: NCT05372484 · RECRUITING
Brief Summary
The study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference standard of histopathology.
Frequently Asked Questions
What is Rice Technologies for Cervical Cancer Screening and Diagnosis?
Rice Technologies for Cervical Cancer Screening and Diagnosis is a clinical trial registered under NCT05372484. Current status: RECRUITING.
What is the status of NCT05372484?
The current status of NCT05372484 (Rice Technologies for Cervical Cancer Screening and Diagnosis) is: RECRUITING.
When did Rice Technologies for Cervical Cancer Screening and Diagnosis start?
Rice Technologies for Cervical Cancer Screening and Diagnosis started on 2021-03-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.